One in seven people offered PrEP in African study start it immediately
New South Wales reports record drop in HIV diagnoses: fewest this year since records began
PrEP use in US exceeds 100,000 in Gilead pharmacy survey
Demand for access to NHS PrEP trial looks set to outstrip places
PrEP demand in England is rapidly accelerating – and most will want to join the trial
Long-acting NRTI shows promise for HIV treatment and PrEP
France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic
Dutch study finds out whether gay men prefer daily or on-demand PrEP
Long-acting cabotegravir injection shows promise for HIV prevention
